Richard James Whitley
CIK: 0001441661
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Dogwood Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Jun 16, 2026DWTX
Dogwood Therapeutics, Inc.
Award(A)DirectStock Option (right to buy)
16.8K shares- - Jun 27, 2025DWTX
Dogwood Therapeutics, Inc.
Award(A)DirectStock Option (right to buy)
2.4K shares- - Jun 18, 2025DWTX
Dogwood Therapeutics, Inc.
Award(A)DirectStock Option (right to buy)
210 shares- - Jun 18, 2025DWTX
Dogwood Therapeutics, Inc.
Award(A)DirectStock Option (right to buy)
210 shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 16, 2026 | DWTX Dogwood Therapeutics, Inc. | Award(A) Stock Option (right to buy) | 16,800 | - | - | Direct |
| Jun 27, 2025 | DWTX Dogwood Therapeutics, Inc. | Award(A) Stock Option (right to buy) | 2,362 | - | - | Direct |
| Jun 18, 2025 | DWTX Dogwood Therapeutics, Inc. | Award(A) Stock Option (right to buy) | 210 | - | - | Direct |
| Jun 18, 2025 | DWTX Dogwood Therapeutics, Inc. | Award(A) Stock Option (right to buy) | 210 | - | - | Direct |
1-4 of 4 transactions
About Whitley Richard James
Whitley Richard James (SEC CIK 0001441661) files insider reports with the SEC as Director of Dogwood Therapeutics, Inc. (DWTX).
Signal8 holds 3 ownership filings by Whitley Richard James, all Form 4s, filed between Jun 23, 2025 and Jun 17, 2026. Those filings report 4 transactions, from Jun 18, 2025 to Jun 16, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Whitley Richard James's filings is in ALPHARETTA, GA.
Recent filings by Whitley Richard James
Other insiders filing for Dogwood Therapeutics, Inc. (DWTX)
- Sealbond Ltd, Director
- De La Rosa Abel, Director
- Thomas John C, Director
- Keefer David R, Director
- Grosswald Ralph, SVP OF OPERATIONS
- Walsh Angela, Chief Financial Officer